The proposed study assesses the superiority of IES supplementation to the standard of care alone (offloading pressure every two hours) in improving the prevention and treatment of sacral and ischial pressure injuries.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
4
The IES system is composed of a stimulator and self-adhesive surface gel electrodes.
Standard institutional practices for treating pressure injury.
Cross Cancer Institute
Edmonton, Alberta, Canada
Clinical course of pressure injury over time
Chauhan Weighted Trajectory Analysis (CWTA) will be used to compare the morbidity associated with sacral and ischial pressure injuries through time. A one-sided Chauhan logrank test at a significance of 0.05 will be used to assess for superiority of the experimental arm over the control arm.
Time frame: Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.
Clinical course of pressure injury in subgroups
Chauhan Weighted Trajectory Analysis (CWTA) will be used to compare the morbidity associated with sacral and ischial pressure injuries through time. A one-sided Chauhan logrank test at a significance of 0.05 will be used to assess superiority.
Time frame: Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.
Kaplan-Meier Time-to-Event Analysis
A Kaplan Meier Curve and logrank Test (one-sided significance at p \< 0.05) will be used to evaluate a difference in sacral and ischial pressure injury time-to-event morbidity between groups. An "event" is defined as the development of any stage/class of pressure ulcer.
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Cox Regression Analysis
Cox-regression analysis will be used to determine whether the implementation of the IES device is associated with a significant difference in sacral and ischial pressure injury time-to-event occurrence between treatment groups.
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Observed Counts of Pressure Injuries
Descriptive statistics and Chi-square testing will be used to compare in incidence rates and proportion between the treatment groups for sacral and ischial pressure injuries classified as Stage I-IV or Unstageable
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Onset Time
Descriptive statistics will be used to report the central tendency and spread of the onset time of a sacral and ischial pressure injury for both treatment groups and for injuries classified as Stage I-IV or Unstageable
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Relative Risk
Relative risk of sacral and ischial pressure injuries will be compared between treatment groups using a 2x2 contingency table with a 95% confidence interval.
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Duration of Inpatient Stay
Descriptive statistics will be used to report the central tendency and spread of the duration of inpatient stay for both treatment groups
Time frame: Final analysis will be performed at end of study (expected completion 2 years)
Description of adverse events related to IES
We will report frequency and severity of skin changes underlying the electrodes, categorized as i) transient erythema after electrode removal, ii) non-transient skin changes after electrode removal, iii) skin breakdown under electrode.
Time frame: Final analysis will be performed at end of study (expected completion 2 years)